i-Base home
Search Menu
  • Home
  • HTB
  • 2002
  • January
  • 10

10 January 2002

Contents

Antiretrovirals

  • Impaired response to HAART found in HIV-positive individuals with high autonomic nervous system activity
  • Anti-HIV effects of the malarial drug chloroquine
  • Treatment guidelines should place more emphasis on CD4+ counts than on viral loads

Paediatric care

  • Birth defects linked to use of certain drugs during pregnancy
  • Immune reconstitution in children treated with HAART is independent of age and pre-treatment immune status

Side effects

  • Doubt over use of antioxidant vitamins for the prevention of coronary disease
  • Endocrine disorders complicate ARV treatment

Coinfections and complications

  • The incidence of non-Hodgkin lymphoma has decreased significantly since the introduction of HAART
  • HAART and CD4+ T cells protect positive people from toxoplasmic encephalitis
  • KS-associated herpesvirus epidemic in San Francisco gay men predates HIV epidemic; oral sex is a likely risk for infection
  • HAART improves anaemia in HIV-positive patients
  • Unexplained vision loss in AIDS patients calls for fluorescein angiography

Cancer and HIV

  • HAART has little effect on anal cancer precursor lesions or on HPV

Basic science and immunology

  • Protease inhibitor based HAART and lymphoid regeneration
  • HTB RSS

Early access

  • AIDS quilts at the Tate: reflection and also anger 8 July 2025
  • US government has altered more than 100 scientific databases since 20 January 5 July 2025
  • All early access reports

Current issues

  • July 2025
  • June 2025
  • May 2025
  • Back issues

Special report

  • AIDS quilts at the Tate: reflection and also anger 8 July 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook